Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares By Investing.com - Investing.com UK

Source: Investing.com UK · 2026-10-06T22:18:00+00:00

Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares By Investing.com Investing.com UK

BestAIBroker analysis

Finance-aware sentiment: slightly negative (-0.10 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 30/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: PTHS, UK.